What is the management strategy for hemorrhagic gastritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hemorrhagic Gastritis

Hemorrhagic gastritis should be managed with aggressive acid suppression using high-dose intravenous proton pump inhibitors (80 mg omeprazole bolus followed by 8 mg/hour infusion for 72 hours), combined with hemodynamic resuscitation, early endoscopy within 12 hours, and endoscopic hemostatic therapy when active bleeding is identified. 1

Initial Resuscitation and Stabilization

  • Maintain restrictive transfusion targets: Keep hemoglobin at 70-90 g/L (trigger at 70 g/L) in patients without cardiovascular disease, or 80-100 g/L in those with cardiac history 1
  • Provide intravascular volume support with crystalloids and blood products as needed to achieve hemodynamic stability 2
  • Monitor continuously with pulse, blood pressure, and urine output measurements following initial stabilization 1

Pharmacological Therapy

Proton Pump Inhibitors (First-Line)

  • Administer high-dose omeprazole: 80 mg IV bolus followed by continuous infusion of 8 mg/hour for 72 hours after successful endoscopic therapy 1
  • This regimen reduces rebleeding rates, blood transfusion requirements, and hospital stay duration 1
  • Continue oral PPI therapy after the initial 72-hour period until complete healing is confirmed 1

Alternative Agents

  • Somatostatin may be considered as it suppresses acid secretion and reduces splanchnic blood flow, though evidence quality is limited 1
  • Historical use of cimetidine showed efficacy in controlling bleeding (12 of 13 patients stopped bleeding), though modern PPIs are preferred 3

Endoscopic Management

Timing and Approach

  • Perform upper endoscopy within 12 hours of presentation once hemodynamic stability is achieved 1, 2
  • Endoscopy serves dual purposes: diagnostic confirmation and therapeutic intervention 1

Endoscopic Therapy Options

  • Thermal hemostasis using heater probes or multipolar coagulation achieves primary hemostasis in up to 95% of patients with GI bleeding 4
  • Apply 20-30 joules repeatedly until a blackened area forms, combining pressure (tamponade) and heat 4
  • Injection therapy or combination approaches may be used for focal bleeding points 1

Repeat Endoscopy Indications

  • Clinical evidence of rebleeding (fresh melena, hematemesis, hemodynamic instability) 1
  • Concerns about suboptimal initial therapy in actively bleeding patients 1
  • Consider repeat intervention 12-24 hours later if initial therapy was difficult 1

Management of Refractory Bleeding

Second Endoscopic Attempt

  • Perform repeat endoscopy to confirm rebleeding and attempt endoscopic therapy once more if stigmata persist 1
  • Do not proceed beyond one repeat endoscopic intervention if unsuccessful 1

Radiological Intervention

  • CT angiography should be performed if patient remains unstable (shock index >1) or active bleeding is suspected despite endoscopic therapy 1
  • Catheter angiography with embolization should follow positive CTA within 60 minutes in unstable patients at centers with 24/7 interventional radiology 1

Surgical Options (Last Resort)

  • Surgery is reserved for patients with uncontrolled hemorrhage despite endoscopic and radiological interventions 1
  • Vagotomy combined with subtotal gastrectomy offers best protection against rebleeding, though mortality remains high at approximately 30% 5, 6
  • Total gastrectomy provides definitive cure but should be considered only as a second procedure after conservative surgery fails, particularly in elderly patients 6
  • Minimum operation (local excision or underrunning) should be performed in elderly patients with poor physical condition 1

Addressing Underlying Causes

Risk Factor Modification

  • Discontinue NSAIDs and aspirin if these are contributing factors 1
  • Test and treat for H. pylori as eradication makes rebleeding extremely rare 1
  • Address alcohol abuse and manage portal hypertension if present 7
  • Treat physiologic stress in ICU patients, as stress is a major predisposing factor 7, 8

Medication Management After Hemostasis

  • If NSAIDs must be continued, use ibuprofen (least damaging) with a PPI 1
  • Consider COX-2 selective anti-inflammatory drugs as an alternative 1

Post-Stabilization Care

  • Allow oral intake 4-6 hours after endoscopy if patient is hemodynamically stable; prolonged fasting is unnecessary 1
  • Continue PPI therapy until complete mucosal healing is documented 1
  • Repeat endoscopy at 6 weeks for gastric lesions to confirm healing and exclude malignancy 1

Common Pitfalls to Avoid

  • Do not delay endoscopy beyond 12 hours, as early intervention improves outcomes 1, 2
  • Do not proceed to emergency laparotomy without exhausting radiological and endoscopic options 1
  • Avoid operating between midnight and 7am when possible, as timing affects outcomes 1
  • Do not use routine prophylactic endoscopy after initial treatment unless specific concerns exist 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Acute Esophageal Variceal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The treatment of hemorrhagic gastritis with cimetidine.

Surgery, gynecology & obstetrics, 1978

Guideline

Heat Therapy for Hematomas: Not Recommended in Acute Phase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute hemorrhagic gastritis--diagnosis and treatment.

Acta chirurgica Scandinavica, 1976

Research

[Surgical treatment of hemorrhagic gastritis].

Journal de chirurgie, 1989

Research

Acute hemorrhagic gastritis.

Gastroenterology clinics of North America, 1993

Research

Hemorrhagic gastritis: current concepts.

Comprehensive therapy, 1978

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.